Prompt engineering-enabled LLM or MLLM and instigative bioinformatics pave the way to identify and characterize the significant SARS-CoV-2 antibody escape mutations
- 8 December 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 287, 138547
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Evaluation of prompt engineering strategies for pharmacokinetic data analysis with the ChatGPT large language modelJournal of Pharmacokinetics and Pharmacodynamics, 2023
- A Domain-Specific Next-Generation Large Language Model (LLM) or ChatGPT is Required for Biomedical Engineering and ResearchAnnals of Biomedical Engineering, 2023
- Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBDJournal of Medical Virology, 2023
- Prompt Engineering with ChatGPT: A Guide for Academic WritersAnnals of Biomedical Engineering, 2023
- Stability and expression of SARS-CoV-2 spike-protein mutationsMolecular and Cellular Biochemistry, 2022
- A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIsGeroScience, 2022
- Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to OmicronGeroScience, 2022
- Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM contextEPMA Journal, 2022
- Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccinesReviews in Medical Virology, 2021
- Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodiesCellular and Molecular Life Sciences, 2020